Revelation Biosciences announces 1-for-4 reverse stock split

Revelation Biosciences (REVB) announced that, on January 28, the company will implement a 1-for-4 reverse split of its common stock. The reverse stock split will be effective as of the morning of January 28, and the company’s common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol “REVB.” The CUSIP number for the common stock following the reverse stock split will be 76135L804.